Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neurosurgery
  Free Subscription

Articles published in
Int J Radiat Oncol Biol Phys
    October 2025
  1. MADISON CJ, Lynch JA, Duvall SL, Alba PR, et al
    Development and Validation of a Computable Radiation Therapy Phenotype.
    Int J Radiat Oncol Biol Phys. 2025;123:583-592.
    >> Share

  2. RAMADAN S, Loblaw A, Dhar A, Fakir H, et al
    PSMA MRI Guided prOstate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of IMaging BiomarkErs Post Radiotherapy (CLIMBER) Phase I/II Trial.
    Int J Radiat Oncol Biol Phys. 2025;123:395-405.
    >> Share

  3. TOM MC, Ghia AJ
    Stereotactic Body Radiation Therapy for Epidural Spinal Cord Compression: Treat Aggressively Now, Avoid Recurrence Later.
    Int J Radiat Oncol Biol Phys. 2025;123:330.
    >> Share

  4. ACEVEDO LA, Awan M
    Radionuclear ESCCalation: Local Therapy for Epidural Spinal Cord Compression in the Context of Peptide Receptor Radionuclide Therapy.
    Int J Radiat Oncol Biol Phys. 2025;123:328-329.
    >> Share

    September 2025
  5. TSANG DS, Murphy E, Salerno KE, Parkes J, et al
    Stereotactic Radiation Therapy in Children and Young Adults: Can We Apply Adult Treatment Paradigms?
    Int J Radiat Oncol Biol Phys. 2025;123:43-53.
    >> Share

    August 2025
  6. MARSHALL J, Bergman A, Karan T, Deyell MW, et al
    Toward the Use of Implanted Cardiac Leads or the Diaphragm for Active Respiratory Motion Management in Stereotactic Arrhythmia Radioablation.
    Int J Radiat Oncol Biol Phys. 2025;122:1344-1355.
    >> Share

  7. LEE HI, Son J, Cho B, Goh Y, et al
    Development and Validation of a Prediction Model for Cardiac Events in Patients With Hepatocellular Carcinoma Undergoing Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:1272-1281.
    >> Share

    July 2025
  8. GUEVARA B, Rezaei A, Baydoun A, Li Q, et al
    In Silico Evaluation of Direct-to-Unit, Single-Visit Celiac Plexus Pain Ablation Using Computed Tomography Guided Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:1054-1059.
    >> Share

  9. PARSONS D, Domal S, Chambers E, Salazar D, et al
    Feasibility and Impact of a Radiation Therapy Technologist-Driven Workflow for Cone Beam Computed Tomography Guided Partial Breast Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:893-901.
    >> Share

  10. CHUONG MD, Mittauer KE, Bassetti MF, Rojas C, et al
    Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction (SMART ONE): A Multicenter, Single-Arm, Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2025;122:957-967.
    >> Share

  11. SNYDER JE, Fast MF, Uijtewaal P, Borman PTS, et al
    Enhancing Delivery Efficiency on the Magnetic Resonance-Linac: A Comprehensive Evaluation of Prostate Stereotactic Body Radiation Therapy Using Volumetric Modulated Arc Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:976-985.
    >> Share

  12. WEI L, Aryal MP, Rice J, Evans J, et al
    Assessing the Relationship Between MR-Based Functional Dose Metrics and Post-Stereotactic Body Radiation Therapy Albumin-Bilirubin Change.
    Int J Radiat Oncol Biol Phys. 2025;122:690-697.
    >> Share

  13. LUKEZ A, Zhang L, Horwitz EM, Galloway TJ, et al
    Computed Tomography-Guided Online Adaptive Stereotactic Body Radiation Therapy for Liver Tumors: A Retrospective Study.
    Int J Radiat Oncol Biol Phys. 2025;122:659-667.
    >> Share

  14. D'SOUZA A, Kang KH, Lattin JE, Kalaghchi B, et al
    Feasibility of Stereotactic Body Radiation Therapy for Pancreatic Tumors Abutting Organs at Risk Using Magnetic Resonance Guided Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:668-677.
    >> Share

  15. MICHALET M, Valenzuela G, Nougaret S, Tardieu M, et al
    Development of Multiparametric Prognostic Models for Stereotactic Magnetic Resonance Guided Radiation Therapy of Pancreatic Cancers.
    Int J Radiat Oncol Biol Phys. 2025;122:678-689.
    >> Share

  16. KISER K, Laugeman E, Beckert R, Kwon M, et al
    Minimizing Bowel Gas Artifact in Computed Tomography Guided Online Adaptive Radiation Therapy With Prolonged Supine Positioning.
    Int J Radiat Oncol Biol Phys. 2025;122:643-647.
    >> Share

  17. WESTERHOFF JM, Scheepens JCM, van Wolffelaar FF, Bernchou U, et al
    Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:698-708.
    >> Share

  18. HOWARD TP, Ferguson D, Han Z, Mamon HJ, et al
    Magnetic Resonance-Guided Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation for Reirradiation in the Abdomen.
    Int J Radiat Oncol Biol Phys. 2025;122:752-759.
    >> Share

  19. JOOYA A, Ly S, Dawson LA, Moreira A, et al
    Patient-Reported Quality-of-Life Outcomes After Abdominopelvic Stereotactic Body Radiation Therapy Using an MR-Linac System.
    Int J Radiat Oncol Biol Phys. 2025;122:770-775.
    >> Share

  20. AKDEMIR EY, Herrera R, Gurdikyan S, Hodgson LC, et al
    Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Infradiaphragmatic Oligometastatic Disease: Disrupting the One-Size-Fits-All Paradigm.
    Int J Radiat Oncol Biol Phys. 2025;122:739-751.
    >> Share

  21. VAN WERKHOVEN LA, Milder MTW, Schillemans W, Hoogeman MS, et al
    Computed Tomography Guided Online Adaptive Stereotactic Body Radiation Therapy for Lymph Node Oligometastases: Impact on Dose to Target and Organs at Risk.
    Int J Radiat Oncol Biol Phys. 2025;122:760-769.
    >> Share

  22. VAN WERKHOVEN LA, Milder MTW, Hoogeman MS, van Werkhoven E, et al
    Results of a Single-Arm Phase 2 Clinical Trial: Online Adaptive Stereotactic Body Radiation Therapy for Abdominal-Pelvic Oligometastases.
    Int J Radiat Oncol Biol Phys. 2025;122:729-738.
    >> Share

    May 2025
  23. FARISELLI L, Marzoli SB, Morlino S, Pinzi V, et al
    Hypofractionated radiosurgery (25 Gy/5 fractions) for optic nerve sheath meningiomas: results from an exploratory phase 2 prospective trial.
    Int J Radiat Oncol Biol Phys. 2025 May 9:S0360-3016(25)00432.
    >> Share

    April 2025
  24. MARCHETTI M, Pinzi V, Gemma M, Cuccarini V, et al
    Hypo-fractionated versus single-session radiosurgery to preserve hearing in patients affected by sporadic vestibular schwannoma. The ACOUNEU randomized clinical trial.
    Int J Radiat Oncol Biol Phys. 2025 Apr 11:S0360-3016(25)00359.
    >> Share

  25. SIMONE CB 2ND, Amini A, Chetty IJ, Choi JI, et al
    American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-small Cell Lung Cancer Executive Summary.
    Int J Radiat Oncol Biol Phys. 2025 Apr 2:S0360-3016(25)00259.
    >> Share

  26. CHAN AW, Zeng KL, Moore-Palhares D, Atenafu EG, et al
    Spine Stereotactic Body Radiation Therapy in Geriatric Patients: Implications of Age and Dose on Iatrogenic Vertebral Compression Fracture Risk.
    Int J Radiat Oncol Biol Phys. 2025;121:1185-1193.
    >> Share

    March 2025
  27. MACCHIA G, Pezzulla D, Campitelli M, Lucci S, et al
    TREATMENT OF OLIGOMETASTATIC PARENCHYMAL LESIONS IN OVARIAN CANCER WITH STEREOTACTIC ABLATIVE RADIOTHERAPY: A MULTICENTER PROSPECTIVE PHASE II TRIAL (MITO RT3/RAD).
    Int J Radiat Oncol Biol Phys. 2025 Mar 31:S0360-3016(25)00262.
    >> Share

  28. SANUKI N, Kimura T, Takeda A, Ariyoshi K, et al
    Final Results of a Multicenter Prospective Study of Stereotactic Body Radiation Therapy for Previously Untreated Solitary Primary Hepatocellular Carcinoma (The STRSPH Study).
    Int J Radiat Oncol Biol Phys. 2025;121:942-950.
    >> Share

  29. HILL CS, Parkinson R, Jaffee EM, Sugar E, et al
    Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic
    Int J Radiat Oncol Biol Phys. 2025;121:930-941.
    >> Share

  30. KLEBANER D, Pollom EL, Rahimy E, Gibbs IC, et al
    Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities from Large Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2025 Mar 13:S0360-3016(25)00242.
    >> Share

    February 2025
  31. UPADHYAY R, Elguindy ANM, Salts L, Donovan K, et al
    Boswellia serrata for cerebral radiation necrosis after radiosurgery for brain metastases.
    Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00153.
    >> Share

  32. REVERBERI C, Facondo G, Prisco A, Ceschia T, et al
    Pre-Operative Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer Patients with Gammapod Technology: Pathological Findings and Ki-67 Evaluation.
    Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00152.
    >> Share

  33. GAETA B, Eichholz JE, Walch H, Ilica AT, et al
    Intracranial disease control and survival among patients with KRAS-mutant lung adenocarcinoma and brain metastases treated with SRS.
    Int J Radiat Oncol Biol Phys. 2025 Feb 8:S0360-3016(25)00093.
    >> Share

  34. SHIN YS, Yun JK, Jung J, Park JH, et al
    Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.
    Int J Radiat Oncol Biol Phys. 2025;121:432-441.
    >> Share

  35. BRAGA-COHEN S, Lavigne J, Dos Santos M, Tarlet G, et al
    Evidence of Alveolar Macrophage Metabolic Shift Following Stereotactic Body Radiation Therapy -Induced Lung Fibrosis in Mice.
    Int J Radiat Oncol Biol Phys. 2025;121:506-519.
    >> Share

  36. GLICKSMAN RM, Raman S, Ye XY, Bedard PL, et al
    The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT): Oncologic Outcomes From a Phase 2 Nonrandomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:292-306.
    >> Share

  37. MOUSTAKIS C, Blanck O, Grohmann M, Albers D, et al
    Planning Benchmark Study for Stereotactic Body Radiation Therapy of Pancreas Carcinomas With Simultaneously Integrated Boost and Protection: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2025;121:547-557.
    >> Share

  38. SHARMA M, Naqa IE, Sneed PK
    Does time to retreatment matter? An NTCP model to predict radionecrosis after repeat SRS for recurrent brain metastases incorporating time-dependent discounted dose.
    Int J Radiat Oncol Biol Phys. 2025 Feb 1:S0360-3016(25)00080.
    >> Share

    January 2025
  39. LATIFI A, Roumeliotis M, Quirk S, Gardner UG, et al
    Brachytherapy Seed Placement by Robotic Bronchoscopy with Cone-Beam CT Guidance for Peripheral Lung Cancer: A Human Cadaveric Feasibility Pilot.
    Int J Radiat Oncol Biol Phys. 2025 Jan 25:S0360-3016(25)00078.
    >> Share

  40. NAGLER F, Vorbach S, Mohamed AA, Thaqi S, et al
    Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma - A multicenter retrospective study.
    Int J Radiat Oncol Biol Phys. 2025 Jan 4:S0360-3016(24)03771.
    >> Share

  41. MURTHY V, Mallick I, Maitre P, Mulye G, et al
    Pelvic regional control with 25Gy in 5 fractions in SBRT for high risk prostate cancer: Pooled prospective outcomes from the SHARP consortium.
    Int J Radiat Oncol Biol Phys. 2025 Jan 2:S0360-3016(24)03773.
    >> Share

  42. SANGUINETI G, D'Urso P, Bottero M, Farneti A, et al
    Stereotactic Radiation Therapy in 3 Fractions for T1 Glottic Cancer.
    Int J Radiat Oncol Biol Phys. 2025;121:145-152.
    >> Share

  43. BALAJI P, Liulu X, Sivakumar S, Chong JJH, et al
    Mechanistic Insights and Knowledge Gaps in the Effects of Radiation Therapy on Cardiac Arrhythmias.
    Int J Radiat Oncol Biol Phys. 2025;121:75-89.
    >> Share

  44. SCHELLENBERG D, Gabos Z, Duimering A, Debenham B, et al
    Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:28-38.
    >> Share

  45. WANG E, Abdallah H, Snir J, Chong J, et al
    Predicting the 3-Dimensional Dose Distribution of Multilesion Lung Stereotactic Ablative Radiation Therapy With Generative Adversarial Networks.
    Int J Radiat Oncol Biol Phys. 2025;121:250-260.
    >> Share

  46. ZHANG P, Happersett L, Burleson S, Oh JH, et al
    Reduction of Postradiation Therapy Urinary Toxicity Via Intrafractional Megavoltage-Kilovoltage Prostate Location Monitoring.
    Int J Radiat Oncol Biol Phys. 2025;121:261-268.
    >> Share

  47. TROJANI V, Grehn M, Botti A, Balgobind B, et al
    Refining Treatment Planning in STereotactic Arrhythmia Radioablation: Benchmark Results and Consensus Statement From the STOPSTORM.eu Consortium.
    Int J Radiat Oncol Biol Phys. 2025;121:218-229.
    >> Share

  48. WANG Y, Dong X, Yan S, Liu B, et al
    Comparison of the Long-term Survival Outcome of Surgery versus Stereotactic Body Radiation Therapy as Initial Local Treatment for Pulmonary Oligometastases from Colorectal Cancer: A Propensity Score Analysis.
    Int J Radiat Oncol Biol Phys. 2025;121:45-55.
    >> Share

    December 2024
  49. MAVRIKIOS A, Baldini C, Loriot Y, Henon C, et al
    Is Local Ablative Stereotactic Radiation Therapy a Valuable Rescue Strategy for Time on Drug in Patients Enrolled in Phase I Trials?
    Int J Radiat Oncol Biol Phys. 2024;120:1245-1256.
    >> Share

  50. NGUYEN TK, Ramadan S, Palma DA, Corkum MT, et al
    Ablative Radiation Therapy to Restrain Everything Safely Treatable (ARREST): A Phase 1 Study of Stereotactic Ablative Radiation Therapy for Polymetastatic Disease.
    Int J Radiat Oncol Biol Phys. 2024;120:1231-1238.
    >> Share

  51. WANG Q, Ji X, Sun J, Zhang A, et al
    Stereotactic Body Radiotherapy Combined With Lenvatinib With or Without PD-1 Inhibitors as Initial Treatment for Unresectable Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024;120:1363-1376.
    >> Share

    November 2024
  52. THARIAT J, Bosset M, Falcoz A, Vernerey D, et al
    Survival without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial in Head and Neck Cancer Patients with Oligometastases using Stereotactic Ablative Radiotherapy (SABR)-alone or chemotherapy SABR.
    Int J Radiat Oncol Biol Phys. 2024 Nov 27:S0360-3016(24)03651.
    >> Share

  53. KEANE FK, Yeap BY, Khandekar MJ, Lin JJ, et al
    Phase II trial of consolidative stereotactic body radiation therapy in patients with metastatic oncogene-driven non-small cell lung carcinoma treated with tyrosine kinase inhibitors.
    Int J Radiat Oncol Biol Phys. 2024 Nov 20:S0360-3016(24)03515.
    >> Share

  54. DOHOPOLSKI M, Schmitt LG, Anand S, Zhang H, et al
    Exploratory Evaluation of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) with CNS-Active Drugs in Brain Metastases Treatment.
    Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03641.
    >> Share

  55. SINGH M, Maitre P, Krishnan A, Adsul K, et al
    Late Urinary Toxicity After Extreme or Moderate Hypofractionated Prostate Radiation Therapy in Patients With Prior Transurethral Resection of Prostate.
    Int J Radiat Oncol Biol Phys. 2024;120:1011-1020.
    >> Share

  56. EHRET F, Furweger C, Liegl R, Schmelter V, et al
    Tumor Control Probability and Time-Dose-Response Modeling for Stereotactic Radiosurgery of Uveal Melanoma.
    Int J Radiat Oncol Biol Phys. 2024;120:1052-1057.
    >> Share

  57. SIMONE CB 2ND
    Enhancing Outcomes in Locally Advanced Non-Small Cell Lung Cancer Through Stereotactic Dose Escalation.
    Int J Radiat Oncol Biol Phys. 2024;120:695-697.
    >> Share

  58. GLICKSMAN RM, Berlin A, Helou J, Loblaw A, et al
    FASTRACKing Our Understanding of Renal Function After Kidney Stereotactic Ablative Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;120:655-657.
    >> Share

  59. ZHANG S, Simard M, Lapointe A, Filion E, et al
    Evaluation of Radiation Dose Effect on Lung Function Using Iodine Maps Derived From Dual-Energy Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2024;120:894-903.
    >> Share

  60. GAUDREAULT M, Hardcastle N, Jackson P, McIntosh L, et al
    Dose-Effect Relationship of Kidney Function After SABR for Primary Renal Cell Carcinoma: TROG 15.03 FASTRACK II.
    Int J Radiat Oncol Biol Phys. 2024;120:648-654.
    >> Share

    October 2024
  61. EHRET F, Baya LE, Erridge SC, Bussiere M, et al
    Radiotherapy for Meningiomas - Where Do We Stand and What's on the Horizon?
    Int J Radiat Oncol Biol Phys. 2024 Oct 28:S0360-3016(24)03525.
    >> Share

  62. ZHANG X, Yan J, Lei Q, Neo J, et al
    A Randomised, Multicentre, Phase II Trial of Camrelizumab with or without Metastasis-directed Stereotactic Body Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024 Oct 23:S0360-3016(24)03512.
    >> Share

  63. SADDOUGHI SA, Kern R
    Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) Lining: We Can All Have a Piece of the Pie.
    Int J Radiat Oncol Biol Phys. 2024;120:357-358.
    >> Share

  64. LI GJ, Tan H, Nusrat H, Chang J, et al
    Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review.
    Int J Radiat Oncol Biol Phys. 2024;120:359-369.
    >> Share

  65. KAMTAM DN, Binkley MS, Kapula N, Sadeghi C, et al
    First in Human Phase 1 Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema.
    Int J Radiat Oncol Biol Phys. 2024;120:345-356.
    >> Share

    September 2024
  66. IGARASHI A, Onishi H, Shioyama Y, Matsumoto Y, et al
    Cost-Utility Analysis of Stereotactic Body Radiation Therapy Versus Surgery for Patients With Stage I Non-small Cell Lung Cancer in Japan.
    Int J Radiat Oncol Biol Phys. 2024 Sep 28:S0360-3016(24)03174.
    >> Share

  67. MACCHIA G, Campitelli M, Pezzulla D, Lucci S, et al
    STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC OVARIAN CANCER LYMPH NODE DISEASE: THE MITO-RT3/RAD PHASE II TRIAL: stereotactic radiotherapy for ovarian cancer nodal metastases.
    Int J Radiat Oncol Biol Phys. 2024 Sep 24:S0360-3016(24)03402.
    >> Share

  68. KENNEDY TAC, Ong WL, Quon H, Cheung P, et al
    Stereotactic radiotherapy for localized prostate cancer: 10-year outcomes from three prospective trials.
    Int J Radiat Oncol Biol Phys. 2024 Sep 16:S0360-3016(24)03368.
    >> Share

  69. GABRIELLA M, Donato P, Maura C, Donatella R, et al
    STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOPROGRESSIVE OVARIAN CANCER PATIENTS TREATED DURING PARP INHIBITOR MAINTENANCE: EFFICACY AND ADVERSE EVENTS FROM THE EPIMETHEO RETROSPECTIVE STUDY.
    Int J Radiat Oncol Biol Phys. 2024 Sep 8:S0360-3016(24)03369.
    >> Share

  70. WOODY NM
    Spare the Knife When Retropharyngeal Lymph Nodes Are Present in Human Papillomavirus-Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2024;120:13.
    >> Share

  71. KOLODZIEJ J, Pintea B, Bostrom JP, Pleger B, et al
    Pain Relief-Related Structural Brain Alterations in Trigeminal Neuralgia Induced by Noninvasive Stereotactic Radiosurgery: A Pilot Study.
    Int J Radiat Oncol Biol Phys. 2024;120:130-136.
    >> Share

  72. TCHELEBI LT, Segovia D, Smith K, Shi Q, et al
    Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas.
    Int J Radiat Oncol Biol Phys. 2024;120:111-119.
    >> Share

    August 2024
  73. TAN VS, Correa RJM, Nguyen TK, Louie AV, et al
    Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE): Long-Term Clinical Outcomes.
    Int J Radiat Oncol Biol Phys. 2024 Aug 8:S0360-3016(24)03173.
    >> Share

  74. CHEN H, Atenafu EG, Zeng KL, Chan A, et al
    Magnetic Resonance Imaging Frequency After Stereotactic Body Radiation Therapy for Spine Metastases.
    Int J Radiat Oncol Biol Phys. 2024;119:1413-1421.
    >> Share

  75. MORAES FY, Gouveia AG, Marta GN, da Silva MF, et al
    Meta-Analysis of Stereotactic Body Radiation ThERapy in Nonspine BONE Metastases (MASTER-BONES).
    Int J Radiat Oncol Biol Phys. 2024;119:1403-1412.
    >> Share

    July 2024
  76. YOO Y, Gibson E, Zhao G, Re TJ, et al
    Extended nnU-Net for brain metastasis detection and segmentation in contrast-enhanced MRI with a large multi-institutional dataset.
    Int J Radiat Oncol Biol Phys. 2024 Jul 24:S0360-3016(24)03138.
    >> Share

  77. SHER DJ, Avkshtol V, Moon D, Vo D, et al
    Stereotactic ablative radiotherapy for T1-2 glottic larynx cancer: mature results from the phase II LT-SABR trial.
    Int J Radiat Oncol Biol Phys. 2024 Jul 20:S0360-3016(24)02972.
    >> Share

  78. LIU W, Feng H, Taylor PA, Kang M, et al
    NRG Oncology and Particle Therapy Co-Operative Group Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies.
    Int J Radiat Oncol Biol Phys. 2024;119:1208-1221.
    >> Share

  79. MOORE-PALHARES D, Zeng KL, Tseng CL, Chen H, et al
    Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure.
    Int J Radiat Oncol Biol Phys. 2024;119:1110-1121.
    >> Share

  80. SINGH R, Valluri A, Lehrer EJ, Cao Y, et al
    Clinical Outcomes After Stereotactic Body Radiation Therapy for Nonspinal Bone Metastases: A Systematic Review and Meta-analysis.
    Int J Radiat Oncol Biol Phys. 2024;119:1099-1109.
    >> Share

  81. KERBA M, Lourenco RA, Sahgal A, Cardet RF, et al
    An Economic Analysis of SC24 in Canada: A Randomized Study of SBRT Compared With Conventional Palliative RT for Spinal Metastases.
    Int J Radiat Oncol Biol Phys. 2024;119:1061-1068.
    >> Share

  82. FREDMAN E, Moore A, Icht O, Tschernichovsky R, et al
    Acute toxicity and early PSA response after two-fraction stereotactic radiotherapy for localized prostate cancer using peri-rectal spacing - Initial report of the SABR-Dual trial.
    Int J Radiat Oncol Biol Phys. 2024 Jul 11:S0360-3016(24)02947.
    >> Share

  83. TOESCA DAS, Hartsell WF, DeWees TA, Chang JH, et al
    Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial.
    Int J Radiat Oncol Biol Phys. 2024 Jul 5:S0360-3016(24)00669.
    >> Share

  84. SCHEP DG, Vansantvoort J, Dayes I, Lukka H, et al
    Evaluation of Volumetric Response Assessment From SABR for Renal Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024;119:832-837.
    >> Share

    June 2024
  85. NI J, Chen H, Yu L, Guo T, et al
    Predicting regional recurrence and prognosis in stereotactic body radiotherapy-treated clinical stage I non-small cell lung cancer using a radiomics model constructed with surgical data.
    Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00743.
    >> Share

    April 2024
  86. GALLITTO M, Sedor G, Lee A, Pasetsky J, et al
    Salvage Stereotactic Radiosurgery for Recurrent WHO Grade 2 and 3 Meningiomas: A Multicenter Study (STORM).
    Int J Radiat Oncol Biol Phys. 2024 Apr 17:S0360-3016(24)00515.
    >> Share

  87. ZHAO J, Vaios E, Wang Y, Yang Z, et al
    Dose-Incorporated Deep Ensemble Learning for Improving Brain Metastasis SRS Outcome Prediction.
    Int J Radiat Oncol Biol Phys. 2024 Apr 12:S0360-3016(24)00505.
    >> Share

  88. MEREDITH EG, Filion E, Faria S, Kundapur V, et al
    Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET).
    Int J Radiat Oncol Biol Phys. 2024 Apr 11:S0360-3016(24)00480.
    >> Share

  89. BIN-ALAMER O, Abou-Al-Shaar H, Peker S, Samanci Y, et al
    Vestibular Schwannoma International Study of Active Surveillance Versus Stereotactic Radiosurgery: the VISAS Study.
    Int J Radiat Oncol Biol Phys. 2024 Apr 6:S0360-3016(24)00482.
    >> Share

  90. BAKER S, Lechner L, Liu M, Chang JS, et al
    Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial.
    Int J Radiat Oncol Biol Phys. 2024;118:1497-1506.
    >> Share

  91. LYNCH C, Korpics MC, Katipally RR, Wu T, et al
    Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases: Safety and Outcomes in a Pooled Analysis of 3 Phase 1 Trials.
    Int J Radiat Oncol Biol Phys. 2024;118:1519-1530.
    >> Share

  92. MERCIER C, Billiet C, Ost P, Joye I, et al
    Long-Term Results of a Phase 1 Dose Escalation Trial of Ablative Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;118:1490-1496.
    >> Share

    March 2024
  93. YASAR B, Suh YE, Chapman E, Nicholls L, et al
    Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancer: Primary outcomes of the SPARC phase II trial.
    Int J Radiat Oncol Biol Phys. 2024 Mar 16:S0360-3016(24)00425.
    >> Share

  94. FAROOQI AS, Yoder AK, Lin HY, Pasalic D, et al
    SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection.
    Int J Radiat Oncol Biol Phys. 2024;118:971-978.
    >> Share

  95. NEILSEN BK, Ma TM, Akingbemi WO, Neylon J, et al
    Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate Stereotactic Body Rad
    Int J Radiat Oncol Biol Phys. 2024;118:986-997.
    >> Share

  96. MILANO MT, Doucette C, Mavroidis P, Yorke E, et al
    Hypofractionated Stereotactic Radiation Therapy Dosimetric Tolerances for the Inferior Aspect of the Brachial Plexus: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2024;118:931-943.
    >> Share

  97. LIU YC, Schmidt RO, Kapadia NS, Phillips JD, et al
    Disparities in access to multidisciplinary cancer consultations and treatment for early-stage non-small cell lung cancer patients: A SEER-Medicare analysis.
    Int J Radiat Oncol Biol Phys. 2024 Mar 13:S0360-3016(24)00426.
    >> Share

  98. YAN W, Ren Z, Chen X, Zhang R, et al
    Potential role of lymphocyte CD44 in determining treatment selection between stereotactic body radiotherapy and surgery for early-stage non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Mar 4:S0360-3016(24)00356.
    >> Share

    February 2024
  99. PATEL KR, Rydzewski NR, Schott E, Cooley-Zgela T, et al
    A Phase I Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2024 Feb 28:S0360-3016(24)00323.
    >> Share

  100. BASCHNAGEL AM, Flakus MJ, Wallat EM, Wuschner AE, et al
    A Phase 2 Randomized Clinical Trial Evaluating 4DCT Ventilation-based Functional Lung Avoidance Radiotherapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00327.
    >> Share

  101. WILLIAMS TM, Miller E, Welliver M, Brownstein J, et al
    A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00324.
    >> Share

  102. REDMOND KJ, Hattangadi-Gluth J, Pollum EL, Trifiletti DM, et al
    Navigating the Spinal Frontier: Recent Data on Stereotactic Body Radiation Therapy for Spine Metastases.
    Int J Radiat Oncol Biol Phys. 2024;118:313-317.
    >> Share

  103. MITTAUER KE, Tolakanahalli R, Kotecha R, Chuong MD, et al
    Commissioning Intracranial Stereotactic Radiosurgery for a Magnetic Resonance-Guided Radiation Therapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation.
    Int J Radiat Oncol Biol Phys. 2024;118:512-524.
    >> Share

  104. REMMERTS DE VRIES IF, Verbakel WFAR, Adema M, Slotman BJ, et al
    Spine Stereotactic Body Radiation Therapy Without Immobilization: Detailed Analysis of Intrafraction Motion Using High-Frequency kV Imaging During Irradiation.
    Int J Radiat Oncol Biol Phys. 2024;118:525-532.
    >> Share

  105. BAE SH, Chun SJ, Chung JH, Kim E, et al
    Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines.
    Int J Radiat Oncol Biol Phys. 2024;118:337-351.
    >> Share

    January 2024
  106. CHEN ATC, Serante AR, Ayres AS, Tonaki JO, et al
    Prospective Randomized Phase 2 Trial of Hypofractionated Stereotactic Radiotherapy of 25 Gy in 5 fractions compared to 35 Gy in 5 fractions in the Reirradiation of Recurrent Glioblastoma.
    Int J Radiat Oncol Biol Phys. 2024 Jan 15:S0360-3016(24)00026.
    >> Share

  107. TRAN PT, Mouw KW
    SABR Today . . . and Tomorrow?
    Int J Radiat Oncol Biol Phys. 2024;118:11.
    >> Share

  108. VELLAYAPPAN B, Lim-Fat MJ, Kotecha R, De Salles A, et al
    A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations.
    Int J Radiat Oncol Biol Phys. 2024;118:14-28.
    >> Share

    December 2023
  109. NEYLON J, Ma TM, Savjani R, Low DA, et al
    Quantifying Intrafraction Motion and the Impact of Gating for MRI-guided Stereotactic Radiotherapy for Prostate Cancer: Analysis of the MRI arm from the MIRAGE Phase III Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2023 Dec 29:S0360-3016(23)08309.
    >> Share

  110. ACHARD V, Zilli T, Lamanna G, Jorcano S, et al
    Urethra-sparing prostate cancer stereotactic body radiotherapy: sexual function and radiation dose to the penile bulb, the crura, and the internal pudendal arteries from a randomized phase 2 trial.
    Int J Radiat Oncol Biol Phys. 2023 Dec 29:S0360-3016(23)08307.
    >> Share

  111. RIMNER A, Gelblum DY, Wu AJ, Shepherd AF, et al
    Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-small Cell Lung Cancer - A Phase I Dose Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2023 Dec 26:S0360-3016(23)08252.
    >> Share

  112. VAIOS EJ, Shenker RF, Hendrickson PG, Wan Z, et al
    Long-term Intracranial Outcomes with Combination Dual Immune-Checkpoint Blockade and SRS in Patients with Melanoma and NSCLC Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2023 Dec 12:S0360-3016(23)08234.
    >> Share

  113. BASSETTI MF, Morris BA, Sethakorn N, Lang JM, et al
    Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase Ib Trial.
    Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08166.
    >> Share

  114. DUDAS D, Saghad PG, Dilling TJ, Perez BA, et al
    Deep Learning-Guided Dosimetry for Mitigating Local Failure of Non-Small Cell Lung Cancer Patients Receiving SBRT.
    Int J Radiat Oncol Biol Phys. 2023 Dec 4:S0360-3016(23)08185.
    >> Share

  115. SAFAVI AH, Palma DA, Giuliani ME
    Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultracentral Thoracic Tumors?
    Int J Radiat Oncol Biol Phys. 2023;117:1232-1235.
    >> Share

  116. SIVA S, Staehler M
    The Right Tool for the Job: The Knife, the SABR, or Fire and Ice?
    Int J Radiat Oncol Biol Phys. 2023;117:1047.
    >> Share

  117. GHALIBAFIAN M, Mirzaei S, Girinsky T, Sadeghi Y, et al
    Challenges in Treating Childhood Infratentorial Ependymoma: A Low- and Middle-Income Country Experience.
    Int J Radiat Oncol Biol Phys. 2023;117:1181-1190.
    >> Share

  118. LINDBERG S, Grozman V, Karlsson K, Onjukka E, et al
    Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2023;117:1222-1231.
    >> Share

  119. LAWRENCE TS, Aryal MP, Evans JR, Cuneo KC, et al
    Does Vascular Collapse Occur After Treatment of Hepatocellular Cancer With Stereotactic Body Radiation Therapy?
    Int J Radiat Oncol Biol Phys. 2023;117:1236-1240.
    >> Share

    November 2023
  120. RITTER AR, Miller ED
    No Regrets About SABR for NETs.
    Int J Radiat Oncol Biol Phys. 2023;117:786.
    >> Share

  121. PARIKH PJ, Lee P, Low DA, Kim J, et al
    A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:799-808.
    >> Share

    September 2023
  122. JEON SH, Jang BS, Kim DY, Kim JH, et al
    Dynamic responses of circulating T cells following stereotactic body radiotherapy for bone metastasis in patients with breast cancer.
    Int J Radiat Oncol Biol Phys. 2023 Sep 22:S0360-3016(23)07932.
    >> Share

  123. LIU F, Ververs JD, Farris MK, William Blackstock A Jr, et al
    Optimal Radiotherapy Fractionation Regimens for Early-Stage Non-Small-Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Sep 19:S0360-3016(23)07929.
    >> Share

  124. PRABHU RS, Akinyelu T, Vaslow ZK, Matsui JK, et al
    Single Fraction vs. Fractionated Preoperative Radiosurgery for Resected Brain Metastases: a PROPS-BM International Multicenter Cohort Study.
    Int J Radiat Oncol Biol Phys. 2023 Sep 15:S0360-3016(23)07924.
    >> Share

  125. ZABROCKA E, Polce S, Roberson JD, Wu J, et al
    Utility of Stereotactic Body Radiation Therapy (SBRT) in Establishing Local Control for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery.
    Int J Radiat Oncol Biol Phys. 2023 Sep 12:S0360-3016(23)07908.
    >> Share

  126. OWEN D, Siva S, Salama JK, Daly M, et al
    Some Like It Hot: The Value of Dose and Hot Spots in Lung Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023;117:1-5.
    >> Share

  127. MENDEZ ROMERO A, van der Holt B, Willemssen FEJA, de Man RA, et al
    Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial).
    Int J Radiat Oncol Biol Phys. 2023;117:45-52.
    >> Share

  128. REYNGOLD M, Karam SD, Hajj C, Wu AJ, et al
    Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:53-63.
    >> Share

    August 2023
  129. GUAN J, Sun K, Guerrero CA, Zheng J, et al
    A Phase 2 study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Aug 23:S0360-3016(23)07836.
    >> Share

  130. UPADHYAY R, Ayan AS, Jain S, Klamer BG, et al
    Dose/volume tolerance of the brain and predictors of radiation necrosis after three-fraction radiosurgery for brain metastases: A large single-institutional analysis.
    Int J Radiat Oncol Biol Phys. 2023 Aug 11:S0360-3016(23)07730.
    >> Share

  131. SHINYA Y, Hasegawa H, Shin M, Kashiwabara K, et al
    Age-Dependent Hemorrhage Risk and Obliteration Benefit After Radiosurgery for Brain Arteriovenous Malformation.
    Int J Radiat Oncol Biol Phys. 2023;116:1126-1134.
    >> Share

    July 2023
  132. KIM IA, Winter KA, Sperduto PW, Santos JFL, et al
    Concurrent lapatinib with brain radiotherapy in HER2+ breast cancer patients with brain metastases - NRG ONCOLOGY-KROG/ RTOG 1119 phase II randomized trial.
    Int J Radiat Oncol Biol Phys. 2023 Jul 26:S0360-3016(23)07681.
    >> Share

  133. OLIVER DE, Laborde JM, Singh DP, Milano MT, et al
    Early-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution Experience.
    Int J Radiat Oncol Biol Phys. 2023;116:849-857.
    >> Share

  134. AMINI A, Rusthoven CG
    Ablative Radiation Therapy for Oligometastatic EGFR-Mutated Non-small Cell Lung Cancer: Who, Why, When, and How?
    Int J Radiat Oncol Biol Phys. 2023;116:481.
    >> Share

    June 2023
  135. CRUZ-LIM EM, Cereno RE, Canal JP, Vega G Jr, et al
    Challenges to Improving Access to Stereotactic Body Radiation Therapy and Radiosurgery in the Philippines: A Case Study for Lower-Middle Income Countries.
    Int J Radiat Oncol Biol Phys. 2023;116:430-438.
    >> Share

    May 2023
  136. MORRIS BA, Holmes EE, Anger NJ, Cooley G, et al
    Toxicity and Patient Reported QoL Outcomes Following Prostate SBRT with Focal Boost to MRI Identified Prostate Cancer Lesions: Results of a Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2023 May 11:S0360-3016(23)00446.
    >> Share

    April 2023
  137. ECHEVARRIA MI, Yang GQ, Chen DT, Kirtane K, et al
    Phase I dose escalation of stereotactic body radiation therapy and concurrent cisplatin for re-irradiation of unresectable, recurrent squamous cell carcinoma of the head and neck.
    Int J Radiat Oncol Biol Phys. 2023 Apr 25:S0360-3016(23)00366.
    >> Share

  138. BUCKNELL NW, Kron T, Herschtal A, Hardcastle N, et al
    Comparison of changes in pulmonary function following stereotactic body radiotherapy versus conventional 3D conformal radiotherapy for stage I and IIa non-small cell lung cancer: an analysis of the TROG 09.02 (CHISEL) phase III trial.
    Int J Radiat Oncol Biol Phys. 2023 Apr 20:S0360-3016(23)00369.
    >> Share

  139. WU TC, Stube A, Felix C, Oseguera D, et al
    Safety and Efficacy Results from iSABR, a Phase I Study of Stereotactic Ablative Radiotherapy (SABR) in Combination with Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer (NSCLC).
    Int J Radiat Oncol Biol Phys. 2023 Apr 4:S0360-3016(23)00325.
    >> Share

  140. GREER MD, Koger B, Glenn M, Kang J, et al
    Predicted Inferior Outcomes for Lung SBRT With Treatment Planning Systems That Fail Independent Phantom-Based Audits.
    Int J Radiat Oncol Biol Phys. 2023;115:1301-1308.
    >> Share

    March 2023
  141. NGUYEN EK, Poon I, Ung YC, Tsao M, et al
    Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023;115:897-905.
    >> Share

  142. SONG X, Wei J, Sun R, Jiang W, et al
    Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Pain Relief for Bone Metastases: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2023;115:909-921.
    >> Share

    February 2023
  143. LIVERINGHOUSE CL, Mills MN, Ahmed KA, Washington IR, et al
    Phase II Study of Preoperative Stereotactic Ablative Body Radiotherapy for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2023 Feb 14:S0360-3016(22)03689.
    >> Share

    January 2023
  144. LEHRER EJ, Kowalchuk RO, Gurewitz J, Bernstein K, et al
    Concurrent administration of immune checkpoint inhibitors and single fraction stereotactic radiosurgery in patients with non-small cell lung cancer, melanoma, and renal cell carcinoma brain metastases is not associated with an increased risk of radiat
    Int J Radiat Oncol Biol Phys. 2023 Jan 20:S0360-3016(23)00057.
    >> Share

    October 2022
  145. ARCIDIACONO F, Anselmo P, Casale M, Zannori C, et al
    STereotactic Ablative RadioTherapy in NEWly diagnosed and recurrent locally advanced non-small cell lung cancer patients unfit for concurrEnt RAdio-chemotherapy: early analysis of the START-NEW-ERA non-randomised phase II trial.
    Int J Radiat Oncol Biol Phys. 2022 Oct 23. pii: S0360-3016(22)03459.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016